Collection
MeSH Terms
Hemophilia B (C16.320.322.235); Hemophilia B (C16.320.099.510); Hemophilia B (C15.378.463.510); Hemophilia B (C15.378.100.141.510); Hemophilia B (C15.378.100.100.510); Hemophilia A (C16.320.099.500); Hemophilia A (C15.378.463.500); Hemophilia A (C15.378.100.141.500); Hemophilia A (C15.378.100.100.500); Factor XIII Deficiency (C15.378.100.100.335);von Willebrand Diseases (C15.378.100.100.900);Blood Coagulation Disorders; Inherited (C15.378.100.100)
Date for Review
n/a
Publication Date
03/08/2020
Date of Last Evidence Search
19-Nov
Methods Applied
Evidence-based & Trustworthy Consensus-Based Statement (TCBS); confidence in the panel composition and screening; systematic and comprehensive evidence searches; formal consensus achievement; transparency of data and methods throughout; rigorous review process.
Guideline Contact
TreatmentGuidelines@WFH.org
Publication Scope
assessment
diagnosis
management
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
World Federation of Hemophilia
Willingness to Collaborate
Yes
Publication Year
2020